• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Automated Software System to Promote Anticoagulation and Reduce Stroke Risk Brief Report
Conclusions—No significant change in OAC prescribing occurred. A greater rate of diagnosis of transient ischemic attack (possibly because of improved detection or overdiagnosis) was associated with a reduction (of borderline significance) in stroke and hemorrhage over 12 months.Clinical Trial Registration—URL: http://www.isrctn.com. Unique Identifier: ISRCTN55722437.
Source: Stroke - February 26, 2017 Category: Neurology Authors: Tim A. Holt, Andrew Dalton, Tom Marshall, Matthew Fay, Nadeem Qureshi, Susan Kirkpatrick, Jenny Hislop, Daniel Lasserson, Karen Kearley, Jill Mollison, Ly-Mee Yu, F.D. Richard Hobbs, David Fitzmaurice Tags: Atrial Fibrillation, Anticoagulants, Health Services, Ischemic Stroke Brief Reports Source Type: research

Electronic Stroke CarePath: Integrated Approach to Stroke Care Innovations in Care
We describe the development, implementation, and outcomes of the first 2 years of the Electronic Stroke CarePath, an initiative developed for management of ischemic stroke patients in an effort to improve efficiency and quality of care for patients. The CarePath consists of care pathways for ischemic stroke that are integrated within the electronic health record. Patient-reported outcomes are collected using an external software platform. Documentation tools, order sets, and clinical decision support were designed to improve efficiency, optimize process measure adherence, and produce clinical data as a byproduct of care th...
Source: Circulation: Cardiovascular Quality and Outcomes - October 29, 2015 Category: Cardiology Authors: Katzan, I. L., Fan, Y., Speck, M., Morton, J., Fromwiller, L., Urchek, J., Uchino, K., Griffith, S. D., Modic, M. Tags: Ischemic Stroke Innovations in Care Source Type: research

Palliative Care Consultation Did Not Reduce Length of Stay in a Comprehensive Stroke Center (P1.212)
Conclusion: Palliative care consultation for patients with ischemic or hemorrhagic strokes was not associated with decreased hospital costs or LoS. This is in contrast to previously reported studies. We will further analyze the effect of early palliative care on a larger sample size to validate the findings. We also propose that a standardized palliative care trigger tool be implemented for early PC consultation in patients with debilitating stroke, advanced age, and multiple comorbid conditions.Disclosure: Dr. Tversky has nothing to disclose. Dr. Cheng has nothing to disclose. Dr. Mahmud has nothing to disclose. Dr. Schlo...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Tversky, S., Cheng, D., Mahmud, S., Schloss, E., Wright, P. Tags: Re-admission and Stroke Outcomes Source Type: research

Application of Machine Learning Techniques to Identify Data Reliability and Factors Affecting Outcome After Stroke Using Electronic Administrative Records
Conclusion: Electronic administrative records from this cohort produced reliable outcome prediction and identified clinically appropriate factors negatively impacting most outcome variables following hospital admission with stroke. This presents a means of future identification of modifiable factors associated with patient discharge destination. This may potentially aid in patient selection for certain interventions and aid in better patient and clinician education regarding expected discharge outcomes.
Source: Frontiers in Neurology - September 27, 2021 Category: Neurology Source Type: research

Outcome Assessment of Acute Ischemic Stroke Patients after Treatment with IV tPA in a Rural Health System (P02.026)
CONCLUSIONS: Patients administered IV tPA for acute ischemic stroke in a rural hospital setting experienced 90-day outcomes similar to those of historical controls. Further attempts to reduce the number of in-hospital complications and reduce time to administration may result in improved patient outcomes.Supported by: Joan Curran Memorial Summer Fellowship in Neurosciences through Gundersen Lutheran Medical Foundation.Disclosure: Dr. Milsap has nothing to disclose. Dr Aldred has received personal compensation for activities with Teva, Ipsen, and Allergan as a speaker and from Teva and Abbot as an advisor. Dr. Aldred has re...
Source: Neurology - February 14, 2013 Category: Neurology Authors: Milsap, A., Aldred, J., Skaar, J. Tags: P02 Cerebrovascular Disease II Source Type: research

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
Conclusions CHA2DS2-VASc accurately stratifies IS risk in individuals with AF across both primary and secondary care. However, the incidence rate of ischaemic stroke at CHA2DS2-VASc=1 are lower than previously reported, which may change the decision to start anticoagulation with warfarin in these individuals.
Source: Heart - January 12, 2017 Category: Cardiology Authors: Allan, V., Banerjee, A., Shah, A. D., Patel, R., Denaxas, S., Casas, J.-P., Hemingway, H. Tags: Open access, Drugs: cardiovascular system, Epidemiology Arrhythmias and sudden death Source Type: research

Researchers examine data to identify optimal vasopressor treatment for rare type of stroke
(University of Texas Health Science Center at Houston) Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
Source: EurekAlert! - Medicine and Health - May 29, 2020 Category: International Medicine & Public Health Source Type: news

Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits
Conclusions and Relevance: The hazard of incident cardiovascular disease is higher in those receiving eiASMs. The association is dose dependent and the absolute difference in hazard seems to reach clinical significance by approximately 10 years from first exposure.PMID:35444497 | PMC:PMC8988723 | DOI:10.1177/15357597211070392
Source: Epilepsy Curr - April 21, 2022 Category: Neurology Authors: David G Vossler Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10